Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Crispr Therapeutics Ag (NQ: CRSP )

100.84 USD UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, May 12, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Crispr Therapeutics Ag

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
25 26 Next >
Better Buy: CRISPR Therapeutics vs. Sangamo Therapeutics
Each company aims to use its genome editing platform to treat disease, but which has an edge? 
Tags VRTX CRSP PFE
From Motley Fool
CRISPR Therapeutics and Vertex Pharmaceuticals Deliever New CTX001 Data
The partners reported encouraging results from the first four patients treated with the CRISPR-based gene-editing therapy. 
Tags Market News CRSP VRTX
From Motley Fool
CRISPR Rally: The First Gene-Editing Drug Continues To Show Promise
Crispr Therapeutics and Vertex Pharmaceuticals stocks popped Friday after the biotech companies unveiled updated results for a gene-editing drug in blood-disease treatment. 
From Investor's Business Daily
The Daily Biotech Pulse: FDA Nod For Viela, 3 IPOs And Hematology Congress Presentations
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags CRSP AGIO CLDX
From Benzinga
Are These The Best Biotech Stocks To Buy Right Now?
From StockMarket.com
July 31st Options Now Available For CRISPR Therapeutics (CRSP)
Investors in CRISPR Therapeutics AG (CRSP) saw new options become available today, for the July 31st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CRSP options... 
Tags Stocks
From Market News Video
How IBD Stock Of The Day Vertex Launched A New Buying Opportunity
Cystic fibrosis treatment maker Vertex Pharmaceuticals is the IBD Stock Of The Day as shares bound into a new buy zone. Shares of VRTX stock bounded off their 50-day moving average. 
From Investor's Business Daily
The Week Ahead In Biotech: Viela FDA Decision, Hematology Conference Take Center Stage
The biotech space saw a flurry of activity last week, with coronavirus-related news, conference presentations and IPOs. Negative ... 
Tags MRUS News PRNB
From Benzinga
3 Top Biotech Stocks to Buy in June
They have one big thing in common: great growth prospects. 
Tags MDGL BMY VRTX
From Motley Fool
July 24th Options Now Available For CRISPR Therapeutics (CRSP)
Investors in CRISPR Therapeutics AG (CRSP) saw new options become available today, for the July 24th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CRSP options... 
Tags Stocks
From Market News Video
Better Buy: CRISPR Therapeutics vs. Intellia
Which gene editing stock wins this matchup? 
Tags REGN VRTX NTLA
From Motley Fool
Why Editas Medicine Is Now the CRISPR Stock to Really Watch
It could soon be Editas' time to shine. 
Tags REGN VRTX CRSP
From Motley Fool
These 4 Biotech Stocks Are Outperforming Their Peers — Here's Why
The best biotech companies to invest in tend to have a commonality: a strong streak of earnings growth. 
From Investor's Business Daily
Here's Why Intellia Therapeutics Gained as Much as 18.0% Today
An existing partner is doubling down on the gene editing platform. 
Tags REGN EDIT CRSP
From Motley Fool
July 10th Options Now Available For CRISPR Therapeutics (CRSP)
Investors in CRISPR Therapeutics AG (CRSP) saw new options become available today, for the July 10th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CRSP options... 
Tags Stocks
From Market News Video
What’s Next For The Biotech Bull Market? Are you a Trader or an Investor?
Despite the economic pains of the pandemic, investors are driven to life science companies in the news with potential solutions for COVID-19. The potential for a COVID-19 vaccine or a new viral... 
Tags ETFs Stocks / Equities Healthcare
From Blogs - TalkMarkets
Is Vertex Pharmaceuticals Stock a Buy?
This successful biotech has two big things going for it. 
Tags ELOX VRTX TBIO
From Motley Fool
How Is COVID-19 Impacting Restaurants?
Our hosts look at some headwinds facing the restaurant industry and how they might survive the pandemic. 
Tags CAKE AMZN SBUX
From Motley Fool
3 Great Stocks to Buy If You Get a Second Stimulus Check
Uncle Sam could be sending more money your way in the not-too-distant future. Buying these stocks will put the extra cash to good use. 
Tags CRSP MA BEP
From Motley Fool
Stocks Showing Market Leadership: CRISPR Therapeutics Earns 92 RS Rating
CRISPR Therapeutics shows rising price performance, earning an upgrade to its IBD Relative Strength Rating. 
From Investor's Business Daily
2 Top Gene Editing Stocks to Watch in June
Here's what's behind two of the most exciting stocks in the gene therapy sector. 
Tags Market News CRSP VRTX
From Motley Fool
The Daily Biotech Pulse: NASH Disappointment For Genfit, Novavax Lands $384M CEPI Funding For Coronavirus Vaccine, GW Pharma Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags CTMX ADPT BHC
From Benzinga
CRISPR Therapeutics Shows Rising Price Performance With Jump To 93 RS Rating
A Relative Strength Rating upgrade for CRISPR Therapeutics shows improving technical performance. 
From Investor's Business Daily
Why CRISPR Therapeutics Soared 13.8% Today
One of the company's pipeline candidates received the orphan drug designation from the FDA. 
Tags Market News CRSP
From Motley Fool
How A Gene-Editing Drug Sent This IBD Stock Of The Day To A New High
Vertex Pharmaceuticals is the IBD Stock Of The Day after the biotech company gained a key designation for its gene-editing drug. Now, Vertex stock is forming an add-on entry. 
From Investor's Business Daily
3 Top Biotech Stocks to Buy in May
These hot biotech stocks should be near the top of your list. 
Tags NVAX GILD SNY
From Motley Fool
3 Reasons to Buy Vertex Pharmaceuticals Stock Right Now
Vertex Pharmaceuticals’ stock has been providing market-beating returns of late. Here’s why it can continue outperforming. 
Tags CRSP VRTX Market News
From Motley Fool
Here's My Top Stock to Buy in May
There are three great reasons to buy this stock sooner rather than later. 
Tags CRSP VRTX Market News
From Motley Fool
Better Buy: Vertex Pharmaceuticals vs. Alexion Pharmaceuticals
Which stock wins in a battle between these two biotechs? 
Tags ALXN VRTX CRSP
From Motley Fool
Better Buy: Crispr Therapeutics vs. bluebird bio
Who wins in a matchup between these two gene-editing leaders? 
Tags VRTX CRSP BMS
From Motley Fool
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
25 26 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback